Marksans Pharma has informed that the Meeting of the Board of Directors of the Company will be held on Monday, 29th May, 2017 at Mumbai, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended 31st March, 2017. The Board of Directors will also consider recommendation of dividend, if any, for the Financial Year 2016-17.
The above information is a part of company’s filings submitted to BSE.